- Home
- PAM vs BFRGW Comparison
PAM vs BFRGW Comparison
Compare PAM & BFRGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAM
- BFRGW
- Stock Information
- Founded
- PAM 1945
- BFRGW N/A
- Country
- PAM Argentina
- BFRGW United States
- Employees
- PAM N/A
- BFRGW 11
- Industry
- PAM Electric Utilities: Central
- BFRGW Retail: Computer Software & Peripheral Equipment
- Sector
- PAM Utilities
- BFRGW Technology
- Exchange
- PAM Nasdaq
- BFRGW Nasdaq
- Market Cap
- PAM 4.8B
- BFRGW N/A
- IPO Year
- PAM N/A
- BFRGW 2023
- Fundamental
- Price
- PAM $93.17
- BFRGW $0.50
- Analyst Decision
- PAM Buy
- BFRGW
- Analyst Count
- PAM 4
- BFRGW 0
- Target Price
- PAM $67.38
- BFRGW N/A
- AVG Volume (30 Days)
- PAM 241.2K
- BFRGW N/A
- Earning Date
- PAM 03-05-2025
- BFRGW N/A
- Dividend Yield
- PAM N/A
- BFRGW N/A
- EPS Growth
- PAM 166.38
- BFRGW N/A
- EPS
- PAM 0.47
- BFRGW N/A
- Revenue
- PAM $2,709,042,561.00
- BFRGW N/A
- Revenue This Year
- PAM N/A
- BFRGW N/A
- Revenue Next Year
- PAM N/A
- BFRGW N/A
- P/E Ratio
- PAM $9.05
- BFRGW N/A
- Revenue Growth
- PAM 221.02
- BFRGW N/A
- 52 Week Low
- PAM $38.15
- BFRGW N/A
- 52 Week High
- PAM $97.55
- BFRGW N/A
- Technical
- Relative Strength Index (RSI)
- PAM 59.47
- BFRGW N/A
- Support Level
- PAM $88.96
- BFRGW N/A
- Resistance Level
- PAM $96.90
- BFRGW N/A
- Average True Range (ATR)
- PAM 3.71
- BFRGW 0.00
- MACD
- PAM -0.18
- BFRGW 0.00
- Stochastic Oscillator
- PAM 66.40
- BFRGW 0.00
About PAM Pampa Energia S.A.
Pampa Energia SA and its subsidiaries are engaged in the Energy business. The operating business segments of the firm are Electricity generation, Electricity distribution, Oil and Gas, Petrochemicals, and Holding and other business. The company derives the maximum revenue from the Distribution of energy.
About BFRGW Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.